elixirgen scientific japan

Elixirgen Scientific, Inc. 日本支店開設のお知らせ

~日本・アジア・パシフィック地域の試薬、細胞事業を拡大
リコーの技術を応用した薬剤応答評価用プレートの開発も加速~

 ヒトiPS細胞由来の分化細胞および幹細胞関連試薬の製造販売を行うElixirgen Scientific, Inc. (本社:米国メリーランド州ボルチモア市) は、日本を中心にアジア・パシフィック地域の試薬、細胞事業拡大を目指し、神奈川県川崎市に日本支店の開設および事業開始したことをお知らせいたします。

Quick-Muscle Skeletal – SeV Complete Kit used in Molecular Therapy paper

BALTIMORE, January 29, 2019 – Elixirgen Scientific’s Quick-Muscle™ Skeletal – SeV Complete Kit (QMS-SeV) was used in a paper that was recently published in Molecular Therapy. Dr. Guangbin Xia (University of New Mexico)’s publication, “Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9” presents his results using CRISPR/Cas9 genome editing and induced pluripotent stem […]

NOG Mouse

Elixirgen Scientific and CIEA (Central Institute for Experimental Animals) to pursue joint research program to develop humanized NOG mice with Quick-Tissue technology

Elixirgen Scientific reached an agreement with CIEA (Central Institute for Experimental Animals), an industry-leading experimental animal model developer, to conduct joint research for developing humanized NOG mice with Quick-Tissue™ technology.